Metgagenomic Analysis of the Human Oral Viral Microbiome
Metgagenomic Analysis of the Human Oral Viral Microbiome
批准号:
7315346
负责人:
Derrick E Fouts
金额:
$19.06万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-01 至 2008-07-31
关键词:
AdhesionsAffectBacteriophagesBiologicalBiotechnologyChairpersonCommunitiesComplementComplementary DNADNADNA SequenceDataData AnalysesDental SchoolsDetectionDiseaseEcologyEcosystemEnvironmentEvaluationFutureGene PoolGenesGenetic VariationGenomicsGingivaGoalsHomeostasisHumanHuman VirusHybridsLettersMarinesMarylandMetagenomicsMethodologyMicrobial BiofilmsMitomycinMouth DiseasesNucleic AcidsNumbersOralOral MicrobiologyOral cavityPathogenesisPlayProceduresProductionProteinsProtocols documentationPublic HealthRNARNA SequencesRoleSalivaSamplingSchool DentistryShotgun SequencingStandards of Weights and MeasuresStructureTechniquesTestingToxinUniversitiesViralVirusauthoritybasegenome sequencinghuman diseaseinsightmicrobialmicrobiomeparticlepathogenprofessortoolvectorviral DNA
中文摘要
描述(申请人提供):鉴于噬菌体在众多生态系统的微生物生态学中所起的作用以及人类病毒在引起口腔疾病中所起的作用,我们正在验证一个假设,(噬菌体和人类病毒)研究发现,人类口腔中的病毒,以及对它们基因组序列的研究,将为病毒在口腔微生物生态学中的作用(如生物膜形成和疾病)提供新的线索。这个发现驱动的R21项目的目标是使用桑格/焦磷酸测序混合采样来确定口腔病毒的遗传多样性,作为对人类口腔病毒组分的基因组能力进行更全面评估的先驱。对口腔内的病毒基因库进行测序将使我们深入了解噬菌体和人类病毒在这种环境中所起的生物作用。有一个具体目标:使用宏基因组学方法了解丝裂霉素C诱导和非诱导人唾液和龈上菌斑样本中的病毒(人病毒和噬菌体)多样性。这种方法与以前通过传统的基于培养的程序鉴定口腔噬菌体的尝试有很大不同。有一些标准的,强大的方法来估计环境样品中的病毒总数,以及新的工具来分析病毒宏基因组数据,这将使多样性和社区结构的估计。在我们的建议中,我们将使用TEM,落射荧光定量技术和桑格/焦磷酸测序杂交方法来获得病毒DNA序列。对这些数据的分析将为未来彻底检查人类口腔中存在的病毒的基因组内容及其在人类疾病中的作用提供框架。公共卫生:这项基于发现的R21提案的目标是确定口腔病毒的遗传多样性,作为更全面地检查人类口腔中病毒基因库的第一步。虽然这项研究并不意味着是全面的,但我们仍将获得对口腔病毒基因内容的宝贵见解,从而更好地了解这些被忽视的载体如何影响体内平衡和疾病。这些数据的未来应用是通过鉴定和生产噬菌体编码的产品来控制细菌病原体。
英文摘要
DESCRIPTION (provided by applicant): Given the roles that bacteriophages have been shown to play in the microbial ecology of numerous ecosystems and the roles that human viruses play in causing oral disease, we are testing the hypothesis that there are a significant number of diverse viruses (both bacteriophage and human viruses) that inhabit the human oral cavity and that examination of their genome sequences will unveil new clues to the role of viruses in the microbial ecology of the mouth (e.g. biofilm formation and disease). The goal of this discovery-driven R21 project is to determine the genetic diversity of oral viruses using Sanger/pyrosequencing hybrid sampling as a precursor to a more comprehensive evaluation of the genomic capacity of the virus component of the human mouth. Sequencing the viral gene pool within the mouth will give insight into the biological role that phage and human viruses play in this environment. There is one specific aim: To use a metagenomic approach to understand viral (both human viruses and bacteriophages) diversity from Mitomycin C-induced and non-induced human saliva and supra- gingival plaque samples. This approach differs significantly from previous attempts to identify oral bacteriophages through traditional culture-based procedures. There are a number of standard, robust methodologies for the estimation of the total numbers of viruses in environmental samples as well as new tools for the analysis of virus metagenomics data that will enable estimation of diversity and community structure. In our proposal, we will use TEM, epifluorescence quantitation techniques and a Sanger/pyrosequencing hybrid approach to obtain virus DNA sequences. Analysis of these data will provide the framework for future thorough examination of the genomic content of the viruses that exist in the human mouth and their role in human disease. Public Health: The goal of this discovery-based R21 proposal is to determine the genetic diversity of oral viruses as the first step to more comprehensive examination of the viral gene pool in the human oral cavity. Though this study is not meant to be comprehensive, we will still gain valuable insight into the gene content of oral viruses, leading to a better understanding of how these overlooked vectors influence homeostasis and disease. A future application of the data is the control of bacterial pathogens through the identification and production of bacteriophage-encoded products.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization, Manufacturing and Testing of a Lead Therapeutic Bacteriophage Cocktail for the Treatment of Antibiotic-Resistant Klebsiella pneumoniae Infections
-
批准号:10674294
-
项目类别:
-
资助金额:$92.13万
-
财政年份:2023
-
负责人:Derrick E Fouts
-
依托单位:
Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)
-
批准号:10490849
-
项目类别:
-
资助金额:$119.88万
-
财政年份:2021
-
负责人:Derrick E Fouts
-
依托单位:
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter
-
批准号:10649550
-
项目类别:
-
资助金额:$146.16万
-
财政年份:2021
-
负责人:Derrick E Fouts
-
依托单位:
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter
-
批准号:10466704
-
项目类别:
-
资助金额:$96.72万
-
财政年份:2021
-
负责人:Derrick E Fouts
-
依托单位:
Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)
-
批准号:10316285
-
项目类别:
-
资助金额:$114.59万
-
财政年份:2021
-
负责人:Derrick E Fouts
-
依托单位:
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter
-
批准号:10402227
-
项目类别:
-
资助金额:$144.82万
-
财政年份:2021
-
负责人:Derrick E Fouts
-
依托单位:
Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)
-
批准号:10655621
-
项目类别:
-
资助金额:$124.3万
-
财政年份:2021
-
负责人:Derrick E Fouts
-
依托单位:
Microbiome as therapeutic target in alcoholic hepatitis
-
批准号:9791138
-
项目类别:
-
资助金额:$30.55万
-
财政年份:2018
-
负责人:Derrick E Fouts
-
依托单位:
Microbiome as therapeutic target in alcoholic hepatitis
-
批准号:10427256
-
项目类别:
-
资助金额:$30.15万
-
财政年份:2018
-
负责人:Derrick E Fouts
-
依托单位:
Microbiome as therapeutic target in alcoholic hepatitis
-
批准号:10198649
-
项目类别:
-
资助金额:$30.15万
-
财政年份:2018
-
负责人:Derrick E Fouts
-
依托单位:
Human Milk Oligosaccharides for Prevention of Alcohol-Associated Liver Disease
-
批准号:10266673
-
项目类别:
-
资助金额:$15.78万
-
财政年份:2018
-
负责人:Derrick E Fouts
-
依托单位:
Genomics of Antibiotic Resistance in Bacterial Pathogens
-
批准号:9032438
-
项目类别:
-
资助金额:$143.22万
-
财政年份:2016
-
负责人:Derrick E Fouts
-
依托单位:
Metgagenomic Analysis of the Human Oral Viral Microbiome
-
批准号:7477267
-
项目类别:
-
资助金额:$23.22万
-
财政年份:2007
-
负责人:Derrick E Fouts
-
依托单位:
海外基金